arrow
S

Sareena Rana

Novartis
H指数:17
被引数:2,485

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2

Pi3kαras结合域的共价抑制剂会损害RAS和HER2驱动的肿瘤生长

SCIENCE
IF45.8
2025-11-130
PRE
Spatial multiplex analysis of lung cancer reveals that regulatory T cells attenuate KRAS-G12C inhibitor-induced immune responses
2024-11-010
OAAI
CRISPR-Cas9 Screening Identifies KRAS-Induced COX2 as a Driver of Immunotherapy Resistance in Lung Cancer

CRISPR-Cas9筛查确定KRAS诱导的COX2是肺癌免疫治疗耐药的驱动因素

2024-04-181
OAAI
An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations
2022-08-0531
OAAI
Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers

治疗性KRASG12C抑制在免疫原性肺癌中驱动有效的干扰素介导的抗肿瘤免疫

2022-07-2259
OAAI
Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

致癌RAS信号通过稳定PD-L1 mRNA促进肿瘤免疫抵抗

IMMUNITY
IF26.3
2017-12-01481
OAAI